These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 5245481)

  • 1. [Serious hematological accidents due to Myleran in the treatment of chronic myeloid leukemia].
    Olmer J; Muratore R; Gabriel B; Canu AM
    Mars Med; 1968; 105(4):330-8. PubMed ID: 5245481
    [No Abstract]   [Full Text] [Related]  

  • 2. [Aplastic syndrome in myleran overdose].
    Albrecht M; Tackmann W; Pribilla W
    Med Klin; 1971 Jan; 66(4):126-30. PubMed ID: 5278287
    [No Abstract]   [Full Text] [Related]  

  • 3. [Aplasia caused by busulfan in chronic myeloid leukemia].
    Perol C; Najean Y; Tanzer J; Jacquillat C; Boiron M; Bernard J
    Nouv Rev Fr Hematol; 1967; 7(6):884-9. PubMed ID: 4230381
    [No Abstract]   [Full Text] [Related]  

  • 4. [The development of aplasia of hematopoiesis after the use of myelosan in patients with chronic myeloleukosis].
    Klimova NF; Cherntsova TA; Protasova TG
    Sov Med; 1967 Dec; 30(12):67-71. PubMed ID: 5250006
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chronic myeloid leukemia treated with busulfan. Clinical characteristics, prognostic factors, effect of treatment and survival in 82 cases].
    Larrain C; Cruz A; Codoceo V
    Rev Med Chil; 1984 Sep; 112(9):898-911. PubMed ID: 6598227
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of chronic myeloid leukemia and lymphoreticular sarcoma with piposulfan].
    Schmidt M; Havemann K
    Dtsch Med Wochenschr; 1970 May; 95(21):1166-70. PubMed ID: 4910386
    [No Abstract]   [Full Text] [Related]  

  • 7. [Survival of 29 cases of chronic myeloid leukemia treated by myleran].
    Petitclerc C; Barry A
    Union Med Can; 1976 Feb; 105(2):210-6. PubMed ID: 1069396
    [No Abstract]   [Full Text] [Related]  

  • 8. [Aplastic anemia following myleran treatment of chronic myeloid leukemia].
    VAN ESSER JG
    Ned Tijdschr Geneeskd; 1958 Feb; 102(8):379-81. PubMed ID: 13541507
    [No Abstract]   [Full Text] [Related]  

  • 9. [Toxic effects of busulfan (myleran) in the treatment of chronic myeolid leukemia].
    Japp H
    Schweiz Med Wochenschr; 1974 Aug; 104(32):1115-9. PubMed ID: 4548568
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of 100 cases of chronic myeloid leukemia with Myleran.
    Pawelski S; Topolska P; Rechowicz K; Krzyzanowska-Wozniakowska
    Pol Med Sci Hist Bull; 1968 Jul; 11(3):101-4. PubMed ID: 5243952
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pulmonary fibrosis after busulfan therapy].
    Jandl H; Franke A; Albrecht G
    Z Gesamte Inn Med; 1975 Dec; 30(24):799-801. PubMed ID: 1062873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cutaneous pigmentations during myeloid leukemia treated with myleran].
    Marchal G; Bilski-Pasquier G; Maunand
    Sem Ther; 1963 Nov; 39(9):565-8. PubMed ID: 5230097
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pulmonary alveolar fibrosis caused by Myleran (busulfan)].
    Etcheberry R; Becker P; Delmastro J; Donoso S
    Rev Med Chil; 1973 Jan; 101(1):42-6. PubMed ID: 4518637
    [No Abstract]   [Full Text] [Related]  

  • 14. [Busulfan lung. Pulmonary fibrosis caused by Myleran].
    Koch H; Lesch R
    Med Welt; 1976 Feb; 27(7):308-11. PubMed ID: 1062649
    [No Abstract]   [Full Text] [Related]  

  • 15. [Survival in chronic myeloid leukemia following aplasia caused by Misulban].
    Perreau P; Gardais J
    Sem Hop; 1969 Mar; 45(15):964-70. PubMed ID: 4307171
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical heterogeneity of Myleran-induced pneumopathy. Apropos of 2 further cases and review of the literature].
    Gyger M; LeGresley LP; Boulianne P; Lacombe M; Lavallée R; Bonny Y; Boileau J; D'Angelo G
    Union Med Can; 1977 Nov; 106(11):1522-8. PubMed ID: 270864
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dysplastic changes of the cervical epithelium caused by busulfan (myleran) (author's transl)].
    Juch E; Lauterbach A
    Geburtshilfe Frauenheilkd; 1982 Jan; 42(1):43-4. PubMed ID: 6949850
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of chronic myeloid leukemia with dibromomannitol].
    Clément F; Saillen R
    Schweiz Med Wochenschr; 1970 Nov; 100(46):1995-7. PubMed ID: 5279364
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hyperlymphocytosis in a case of busulfan-induced medullar aplasia in chronic myeloid leukemia. Chromosome and functional study].
    Negrini AC; Azzolini A; Bertocchi I; Dolcino G
    Pathologica; 1967; 59(879):407-10. PubMed ID: 5273096
    [No Abstract]   [Full Text] [Related]  

  • 20. [Analysis of results of treatment with myleran in 100 cases of chronic myelogenous leukemia].
    Pawelski S; Topolska P; Rechowicz K; Krzyzanowska-Woźniakows
    Pol Arch Med Wewn; 1968; 41(2):249-57. PubMed ID: 5248892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.